mHealth to Improve the Experience, Adherence to Drug Treatment and Positive Mental Health
1 other identifier
interventional
278
1 country
1
Brief Summary
The present study aims to evaluate the effectiveness of a pharmacological nursing educational intervention (EFE) with "Myplan Aplication" about the patient's experience, adherence to pharmacological treatment, and positive mental health of patients with femur fracture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 21, 2022
CompletedFirst Submitted
Initial submission to the registry
December 2, 2022
CompletedFirst Posted
Study publicly available on registry
December 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedDecember 30, 2022
December 1, 2022
1 month
December 2, 2022
December 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Patient experience questionnaire-15. Changes in outcomes are assessed at three time points.
This questionnaire allows us to explore the perception of patients about the information process and participation in decision-making during hospital admission. The responses range is from always or almost always/quite frequently/sometimes/never or almost never.This questionnaire allows us to explore the perception of patients about the information process and participation in decision-making during hospital admission. The responses range from always or almost always/quite frequently/sometimes/never or almost never.
at 1rst day (before intervention), at 7th day (at discharge after intervention), and 25th day (after discharge)
Morinski-Green Questionnaire. Changes in outcomes are assessed at three time points.
This questionnaire allows assessing adherence to the prescribed treatment. It consists of a series of 4 dichotomous yes/no questions that reflects the degree of behavior of the patient's compliance, information on the causes of non-compliance.
at 1rst day, at 7th day and 25th day.
Positive Mental Health Questionnaire. Changes in outcomes are assessed at three time points.
This scale evaluates mental health from a positive perspective. It consists of 39 items distributed in six factors: personal satisfaction, pro-social attitude, self-control, autonomy, problem solving and self-acting, and interpersonal relationship skills. Its measurement is carried out by means of a Likert-type response that goes from always or almost always, quite frequently, sometimes, never or almost never. Validated in the general population in favorable psychometric values: global reliability of 0.88 and an applied variance of 45%.
at 1rst day, at 7th day and 25th day.
Study Arms (3)
Patient experience
ACTIVE COMPARATORAdherence to drug treatment
ACTIVE COMPARATORPositive mental health
ACTIVE COMPARATORInterventions
Inform the patient of the medication that is being taken and how it has to be taken; What is it for and the side effects and/or adverse reactions.
Review of the use of the aplication
* How do you feel? * Sad feelings and frustration. * Achievements day by day, think positive. * Importance of interpersonal relationships. * Explain activities to relax the mind
Eligibility Criteria
You may qualify if:
- diagnosis of femur fracture
- knowledge of the Spanish language
- hour admission to the traumatology unit
- level of consciousness on the Glasgow scale of 15
- have access to a mobile device
- ability to participate in the pilot study
- be able to provide written informed consent or obtain consent from a legal representative.
You may not qualify if:
- presence of psychological pathologies or cognitive impairment
- isolation in hospital admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Clinic of Barcelonalead
- Amgencollaborator
- University of Barcelonacollaborator
Study Sites (1)
Hospital Clinic de Barcelona
Barcelona, 08036, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Carmen Moreno Arroyo
UB
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 2, 2022
First Posted
December 30, 2022
Study Start
November 21, 2022
Primary Completion
January 1, 2023
Study Completion
April 1, 2023
Last Updated
December 30, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- February 2024
- Access Criteria
- Healthcare professionals
* Publication of an article with preliminary results in the BioMed Central Public Health magazine. * Presentation of results at National Congress of Mental Health Nursing. Spain. * Publication of results article in "Revista Española de Enfermería de Salud Mental" magazine. * Presentation of results at Investen, Annual Meeting on Care Research. Spain.